日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mevalonate supplementation to enhance euploid embryo formation in women of advanced maternal age: a study protocol for a randomized controlled trial

甲羟戊酸补充剂促进高龄产妇正常染色体胚胎形成:一项随机对照试验的研究方案

Wang, Shanshan; Zhang, Yonghong; Wang, Lingjuan; Fang, Junshun; Ye, Xiaoping; Sun, Yanxin; Sun, Haixiang

Tumor-derived immunoglobulin-like transcript 3 inhibition reshapes the immunosuppressive tumor microenvironment and potentiates programmed cell death ligand 1 blockade immunotherapy in lung adenocarcinoma.

肿瘤来源的免疫球蛋白样转录物 3 抑制重塑免疫抑制性肿瘤微环境,并增强肺腺癌中程序性死亡配体 1 阻断免疫疗法的疗效

Wang Leirong, Li Qing, Sun Yanxin, Wang Shuyun, Fu Xuebing, Wang Xiufen, Zheng Yan, Gao Aiqin, Sun Yuping, Li Juan

Efficacy of PD-(L)1 inhibitors plus anlotinib in the second-line treatment of extensive-stage small cell lung cancer

PD-(L)1抑制剂联合安罗替尼二线治疗广泛期小细胞肺癌的疗效

Zhang, Jian; Wu, Zijie; Wang, Shuyun; Sun, Yanxin; Wu, Jiake; Wang, Dahai; Ge, Yihui; Li, Juan; Sun, Haifeng; Cheng, Qinglei; Gao, Aiqin; Sun, Yuping

Optimization of First-Line Treatment Options in HER2-Altered Lung Adenocarcinoma: A Real-World Study.

HER2 改变的肺腺癌一线治疗方案优化:一项真实世界研究

Wang Xiufen, Wang Dahai, Sun Yanxin, Gan Yiling, Li Juan, Fu Xuebing, Ge Yihui, Wang Shuyun, Wang Leirong, Sun Haodong, Sun Haifeng, Sun Yuping, Gao Aiqin

Impact of irae characteristics on efficacy of consolidative immunotherapy following chemoradiotherapy in locally advanced NSCLC.

irae 特征对局部晚期 NSCLC 化疗放疗后巩固性免疫治疗疗效的影响

Wang Xiufen, Fu Xuebing, Liu Qiaohong, Li Juan, Ge Yihui, Zhang Jian, Wang Shuyun, Wang Leirong, Wang Dahai, Sun Yanxin, Gan Yiling, Sun Haodong, Wang Zhen, Sun Yuping, Gao Aiqin

Targeting m7G-enriched circKDM1A prevents colorectal cancer progression

靶向 m7G 富集的 circKDM1A 可预防结直肠癌进展

Zhenqiang Sun #, Yanxin Xu #, Chaohua Si #, Xiaoke Wu, Yaxin Guo, Chen Chen, Chengzeng Wang

Exosomal circPOLQ promotes macrophage M2 polarization via activating IL-10/STAT3 axis in a colorectal cancer model

外泌体 circPOLQ 通过激活 IL-10/STAT3 轴促进结直肠癌模型中巨噬细胞的 M2 极化

Zhenqiang Sun # ,Yanxin Xu # ,Bo Shao # ,Pengyuan Dang ,Shengyun Hu ,Haifeng Sun ,Chen Chen ,Chaoguan Wang ,Jinbo Liu ,Yang Liu ,Junhong Hu

Correlation between immune-related adverse events and efficacy of PD-(L)1 inhibitors in small cell lung cancer: a multi-center retrospective study

免疫相关不良事件与PD-(L)1抑制剂在小细胞肺癌中的疗效之间的相关性:一项多中心回顾性研究

Zhang, Jian; Gao, Aiqin; Wang, Shuyun; Sun, Yanxin; Wu, Jiake; Wang, Dahai; Ge, Yihui; Li, Juan; Sun, Haifeng; Cheng, Qinglei; Sun, Yuping

Research progress and prospect of postoperative adjuvant therapy for resectable intrahepatic cholangiocarcinoma

可切除肝内胆管癌术后辅助治疗的研究进展及展望

Sun, Yanxin; Jiang, Wei; Duan, Ruiheng; Guan, Lianyue

Efficacy of first-line treatment options beyond RET-TKIs in advanced RET-rearranged non-small cell lung cancer: A multi-center real-world study

RET-TKI 以外的一线治疗方案在晚期 RET 重排非小细胞肺癌中的疗效:一项多中心真实世界研究

Ge, Yihui; Li, Juan; Gong, Wenjing; Wang, Jian; Wei, Xiaojuan; Liu, Jing; Wang, Shuyun; Wang, Leirong; Sun, Haifeng; Cheng, Qinglei; Sun, Yanxin; Dang, Qi; Sun, Yuping; Gao, Aiqin